Studien | Der Arzneimittelbrief

ALLOZITHRO

Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

ALLRT

AIDS clinical trials group Longitudinal Linked Randomized Trials

ALLSTAR

RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors

ALLY

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

ALLY-1

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Subjects and Subjects Post-liver Transplant

ALLY-2

Phase III HIV/HCV Co-Infection Daclatasvir (DCV)+ Sofosbuvir (SOF)

ALLY-3

Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

ALLY-3C

A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection

ALM

Arbeitsgruppe LeberMetastasen

ALM-CAO

Arbeitsgruppe Lebermetastasen und -tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie

ALMANAC

Axillary Lymphatic Mapping Against Nodal Axillary Clearance

ALMS

Aspreva Lupus Management Study

ALNN

Asian Lupus Nephritis Network

ALOFT

ALiskiren Observation of heart Failure Treatment

ALOHA

Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern

ALONE AF

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation

ALONE-AF

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation

ALPACA

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

AlPaCKa

Apelin as a Potential Treatment for Chronic Kidney Disease

ALPADIR

A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients

ALPHA

Analysing Longitudinal Population-based HIV/AIDS data on Africa

ALPHA

Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)

ALPHA

Predictors of Mortality and Hospitalization for Cardiac Causes in Patients With Heart Failure and Nonischemic Heart Disease

ALPHA

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Alpha Omega Trial

Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality

Alpha-Stim-D

A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care

ALPHA2/ALPHA

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

AlphaBet

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer

ALPHEE

Amiodarone as calibrator for the prevention of implantable cardioverter defibrillator interventions or death

ALPI

Adjuvant Lung Project Italy

ALPINE

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

ALPINE

Antihypertensive treatment and Lipid Profile In a North of Sweden Efficacy evaluation

Alpine CHRIS

Cooperative Health Research In South Tyrol

ALPS

Aggressive Hydration With Lactated Ringer's Solution Versus Plasma Solution for the Prevention of Post ERCP Pancreatitis

ALPS

Amiodarone, Lidocaine or Placebo Study

ALPS

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

ALS riluzole-tocopherol Study

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis

ALSPAC

Avon Longitudinal Study of Parents And Children

ALSPAC

Avon Longitudinal Study of Pregnancy And Childhood

ALSTAR2

Functionally Validated Structural Endpoints for Early AMD

Alster-Lost-AF Trial

Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation

ALSummit

Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS

ALSWH

Australian Longitudinal Study on Women’s Health

ALSYMPCA

ALpharadin in SYMPtomatic prostate CAncer patients

ALt FLOW CANADA

Exploratory Study of the Edwards Transcatheter Atrial Shunt System

ALT FLOW Early Feasibility Study

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

ALTA-1L

ALK in Lung cancer Trial of Brigatinib in 1st Line

ALTAI

A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)

ALTAIR

Abatacept Leading Trial for RA on Imaging Remission

ALTAIR

ALTernative Antiretroviral strategies: a comparison of three Initial Regimens

ALTAIR

Efficacy of ALirocumab for Thin-cap fibroatheroma in patients with coronary Artery disease estImated by optical coherence tomography

ALTAR

ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women

ALTE1621

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

ALTERNATE

Assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2− invasive breast cancer

ALTERNATIVE

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

ALTERNATIVE-AF

Comparison of His Bundle Pacing and Bi-Ventricular Pacing in Heart Failure With Atrial Fibrillation

ALTERRA

SAPIEN 3 THV With the Alterra Adaptive Prestent

ALTITUDE

ALiskiren Trial In Type 2 diabetes Using carDio-renal Endpoints

ALTITUDE

Long-term outcome after ICD and CRT implantation and influence of remote device follow-up